Chemoinformaics analysis of Chrysanthenone
Molecular Weight | 150.221 | nRot | 0 |
Heavy Atom Molecular Weight | 136.109 | nRig | 9 |
Exact Molecular Weight | 150.104 | nRing | 3 |
Solubility: LogS | -3.686 | nHRing | 0 |
Solubility: LogP | 2.892 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.8371 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.518 |
Synth | 4.417 |
Natural Product Likeliness | 2.146 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.142 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.544 |
MDCK | 0.000026 |
BBB | 0.152 |
PPB | 0.899546 |
VDSS | 1.108 |
FU | 0.103456 |
CYP1A2-inh | 0.663 |
CYP1A2-sub | 0.803 |
CYP2c19-inh | 0.643 |
CYP2c19-sub | 0.878 |
CYP2c9-inh | 0.179 |
CYP2c9-sub | 0.697 |
CYP2d6-inh | 0.461 |
CYP2d6-sub | 0.718 |
CYP3a4-inh | 0.029 |
CYP3a4-sub | 0.418 |
CL | 4.952 |
T12 | 0.285 |
hERG | 0.01 |
Ames | 0.014 |
ROA | 0.157 |
SkinSen | 0.174 |
Carcinogencity | 0.243 |
EI | 0.508 |
Respiratory | 0.927 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.925157 |